Exponent, Inc. (EXPO) Stake Decreased by New York State Common Retirement Fund

New York State Common Retirement Fund trimmed its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 12.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 50,700 shares of the business services provider’s stock after selling 7,400 shares during the quarter. New York State Common Retirement Fund owned about 0.10% of Exponent worth $2,571,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its position in shares of Exponent by 3.4% during the 3rd quarter. BlackRock Inc. now owns 7,481,717 shares of the business services provider’s stock valued at $401,018,000 after acquiring an additional 243,202 shares during the period. Vanguard Group Inc lifted its position in shares of Exponent by 2.8% during the 3rd quarter. Vanguard Group Inc now owns 5,147,145 shares of the business services provider’s stock valued at $275,887,000 after acquiring an additional 139,183 shares during the period. Vanguard Group Inc. lifted its position in shares of Exponent by 2.8% during the 3rd quarter. Vanguard Group Inc. now owns 5,147,145 shares of the business services provider’s stock valued at $275,887,000 after acquiring an additional 139,183 shares during the period. Conestoga Capital Advisors LLC lifted its position in shares of Exponent by 2.6% during the 4th quarter. Conestoga Capital Advisors LLC now owns 2,310,721 shares of the business services provider’s stock valued at $117,177,000 after acquiring an additional 57,955 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in shares of Exponent by 2.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 779,747 shares of the business services provider’s stock valued at $41,794,000 after acquiring an additional 20,703 shares during the period. Hedge funds and other institutional investors own 89.36% of the company’s stock.

Shares of EXPO stock opened at $56.94 on Thursday. Exponent, Inc. has a twelve month low of $38.17 and a twelve month high of $58.29. The firm has a market cap of $2.96 billion, a P/E ratio of 45.55 and a beta of 0.47.



Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Thursday, January 31st. The business services provider reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.01. Exponent had a return on equity of 21.53% and a net margin of 19.04%. The business had revenue of $85.27 million during the quarter, compared to the consensus estimate of $88.21 million. On average, analysts predict that Exponent, Inc. will post 1.37 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 22nd. Investors of record on Friday, March 8th will be given a dividend of $0.16 per share. This is an increase from Exponent’s previous quarterly dividend of $0.13. This represents a $0.64 annualized dividend and a dividend yield of 1.12%. The ex-dividend date is Thursday, March 7th. Exponent’s dividend payout ratio is currently 51.20%.

In related news, insider Harri Kytomaa sold 2,366 shares of the company’s stock in a transaction on Friday, February 22nd. The stock was sold at an average price of $56.27, for a total transaction of $133,134.82. Following the completion of the sale, the insider now directly owns 3,816 shares in the company, valued at approximately $214,726.32. The sale was disclosed in a filing with the SEC, which is available through this link. 2.70% of the stock is owned by corporate insiders.

A number of research firms have recently weighed in on EXPO. ValuEngine upgraded Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, December 13th. BidaskClub downgraded Exponent from a “buy” rating to a “hold” rating in a research report on Thursday, December 6th. Zacks Investment Research downgraded Exponent from a “buy” rating to a “hold” rating in a research report on Thursday, January 17th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $56.00 target price on shares of Exponent in a research report on Tuesday, January 15th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $56.00.

ILLEGAL ACTIVITY NOTICE: “Exponent, Inc. (EXPO) Stake Decreased by New York State Common Retirement Fund” was first reported by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://dakotafinancialnews.com/2019/03/21/exponent-inc-expo-stake-decreased-by-new-york-state-common-retirement-fund.html.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Featured Story: Trading Ex-Dividend

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.